Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 92

Results For "human"

1081 News Found

Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
Clinical Trials | December 30, 2021

Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA

The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness


Expectations and predictions for 2022
Opinion | December 28, 2021

Expectations and predictions for 2022

In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc


Trastuzumab deruxtecan type II variation application validated by EMA
Biotech | December 28, 2021

Trastuzumab deruxtecan type II variation application validated by EMA

Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1)


Indian Pharmaceutical Market grew at 6.6 pc in November
News | December 24, 2021

Indian Pharmaceutical Market grew at 6.6 pc in November

Flattish volume growth and subdued new launches were key factors for last month


Granules India appoints Sucharita Rao Palepu as Non-executive Independent Director
People | December 24, 2021

Granules India appoints Sucharita Rao Palepu as Non-executive Independent Director

Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services


Piramal Pharma takes a minority stake in Yapan Bio
Biotech | December 22, 2021

Piramal Pharma takes a minority stake in Yapan Bio

The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space


World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
News | December 22, 2021

World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster

SAGE recommends additional third dose of the vaccine administered to immunocompromised persons


Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA
Biotech | December 21, 2021

Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA

Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers


NMPA approves CStone's NDA for Cejemly
Drug Approval | December 21, 2021

NMPA approves CStone's NDA for Cejemly

The NMPA approval is based on the positive data of GEMSTONE-302 study, a multi-center, randomized, double-blind, phase III study that evaluated the efficacy and safety of Cejemly or placebo in combination with chemotherapy in first-line stage IV NSCLC patients


Salesforce and Azim Premji Foundation launch VaxIT app to speed up Covid-19 vaccination
Public Health | December 21, 2021

Salesforce and Azim Premji Foundation launch VaxIT app to speed up Covid-19 vaccination

The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress